FDA Drug recall D-0946-2017
Succinylcholine Chloride, 100 mg per 5mL, 20 mg per mL syringe
- FDA Drug
- Class II
- terminated
- Published 2017-07-12
On 2017-07-12 the FDA classified a Class II recall of Succinylcholine Chloride, 100 mg per 5mL, 20 mg per mL syringe by Fagron Compounding Services, citing lack Of Assurance Of Sterility: voluntary recall initiated by the commercial supplier.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0946-2017 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2017-06-19 |
| Published | 2017-07-12 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Fagron Compounding Services |
| Distribution | US |
Product
Succinylcholine Chloride, 100 mg per 5mL, 20 mg per mL syringe. IV Use Only. JCB Laboratories, 8710 E 34th St., N. Wichita, KS 67226 UPC 7335968405
Reason
Lack Of Assurance Of Sterility: voluntary recall initiated by the commercial supplier
Identifiers
| code_info | Lot #: C274-000000331, BUD 08/30/2017; C274-000001274, BUD 09/07/2017; C274-000001326, BUD 09/14/2017 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0946-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.